Skip to main content
logo
HomeUS StocksRMD

R

$ 236.57

-0.31 (-0.13%)loss
as on 21 Nov 2026 at 01:22 AM IST
analyst63.64% Hold
Overview
News
History
Fundamentals
Investment Returns
Financials
Balance Sheet
Cash Flow
Corporate Actions
Peers

Resmed Share Price Today

Resmed (RMD) share price is $236.57 on the NYSE as of November 21, 2026 at 01:22 AM IST, down 0.13% ($0.31) from its previous close of $236.88. In rupee terms, one share is worth about ₹21,953.79 at today's USD/INR rate of 92.80. In today's trading session RMD reached a high of $242.43 and low of $235.92.

Stock Overview

  • Symbol : RMD
  • Open : $237.18
  • Previous Close : $236.88
  • Day's Range : $235.92 – $242.43
  • 52-Week Range : $180.27 – $277.67
  • Price in INR : ₹21,953.79 (USD/INR: 92.80)

RMD Stock Performance ($)

Markets Today

High

242.43

Low

235.92

Open at

237.18

Prev Close

236.88

Volumes

6,56,437

Price Movement

235.92242.43
0.28%Loss
down side
up side
2.42%Profit

Historical Performance

3 M High

255.57

3 M Low

215.80

1 Yr High

277.67

1 Yr Low

180.27

3 Yr High

293.81

3 Yr Low

148.03

5 Yr High

293.81

5 Yr Low

132.24

1-Year Performance

180.27277.67
31.24%Loss
down side
up side
14.80%Profit

RMD Analyst Rating

Hold

Analysts have suggested that investors can Hold this Stock

- By ViewTrade from 11 analysts

Buy

36.36%

Hold

63.64%

Sell

0%

RMD Latest News



RMD Share Price History ($)

Close Price

Volume

RMD share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
19 Nov 2026242.48237.00
-2.26% Loss
242.99236.028,11,479
18 Nov 2026236.38242.64
2.65% profit
246.14236.148,88,701
17 Nov 2026237.00237.97
0.41% profit
241.22233.427,97,174
16 Nov 2026240.00238.25
-0.73% Loss
243.00238.107,23,368
13 Nov 2026241.20239.54
-0.69% Loss
241.86239.136,02,850
12 Nov 2026238.78238.96
0.08% profit
243.45237.838,24,665
11 Nov 2026230.63238.52
3.42% profit
238.60230.006,49,572
10 Nov 2026234.49234.07
-0.18% Loss
235.85231.138,81,780
09 Nov 2026236.57235.75
-0.35% Loss
237.84231.318,96,872
06 Nov 2026234.00235.32
0.57% profit
236.67231.9512,81,111

RMD Fundamentals

Company Valuation

Market Cap

$33,275.37M

PE Ratio

21.82

PEG Ratio

0.83

PB Ratio

5.66

ROE

24.19%

ROCE

25.63%

RESMED INC Return Calculator

You have invested
Investment Period

Current value of ₹10,000 invested 5 years ago, as on today

₹ 0

Loss

₹ 10,000 (9.12%)

Note: Past profits do not guarantee future returns.

RMD Investment Returns

1 Week

1 Month

3 Months

6 Months

RMD Financials Summary

Revenue
EBITDA
Net Profit
EPS
Revenue

($ Mn)

Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
1,3361,4231,4311,4641,415

RMD Financials

Income Statement

($ Mn)

Quarterly StatementSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
1,3361,4231,4311,4641,415
Expenses8739259321,015962
Operating Profit462498500449453
Operating Profit Margin %35%35%35%31%32%
Other Income-4-5-110
520560500449453
Interest16132586
Depreciation5862000
447496502474539
Tax %22%21%21%19%22%
Net Profit349393399383418
EPS23333

Balance Sheet

($ Mn)

Yearly Balance SheetMar 2025Sep 2025Dec 2025Mar 2026Sep 2026
7,5678,3088,5038,7848,212
Fixed Assets688726730729798
Current Assets3,2083,6263,8194,0643,509
Capital Work in Progress688726730729798
Investments00000
Other Assets175190194211209
7,5678,3088,5038,7848,212
Current Liabilities9411,2561,2481,3511,324
Non Current Liabilities1,080932934941940
5,5466,1216,3216,4925,948
Reserve & Surplus5,5296,2826,6176,9347,447
Share Capital1,9912,0632,1042,1352,134

Cash Flow

($ Mn)

Quarterly Cash FlowSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Cash from Operating457340554455422
Cash from Investing-53-51-58-384392
Cash from Financing-230-258-255-263-1,278
Net Cash Flow17430241-192-464

Corporate Actions

DateCorporate ActionInformation
12th Nov 2026, Thursday
DIVIDENDDividend
Cash Dividend of $0.66/share
20th Aug 2026, Thursday
DIVIDENDDividend
Cash Dividend of $0.66/share

The above dates are ex-dates.

RMD Revenue Growth

All values are ($ Mn)

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2025-265,653
9.85% Profit
1,523
8.75% Profit
FY 2024-255,146
9.84% Profit
1,401
37.2% Profit
FY 2023-244,685
10.95% Profit
1,021
13.75% Profit

RMD Similar Stocks

Stock NamePriceChange %VolumeMarket Cap ($Mn)PE Ratio
Abbott Labs

A

Abbott Labs

$103.87
-0.58%loss
5,685 1,79,89740.49
Intuitive Surgical

I

Intuitive Surgical

$407.24
-3.26%loss
2,283 1,41,16753.64
Medtronic

M

Medtronic

$100.61
-0.11%loss
1,110 1,28,69725.27
Stryker

S

Stryker

$313.08
-1.59%loss
1,198 1,19,18732.98
Boston Scientific

B

Boston Scientific

$42.99
-1.49%loss
9,849 62,31318.71

Invest in US Stocks with Dhan

Start building a global portfolio from just $1.

4.5 ratings

4.0 ratings

Dhan US Stocks App

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES/SMART ODR Portal: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com›store›apps›sebiscores iOS: https://apps.apple.com›app›sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

SEBI presents Samajh Se Investing Simple:

  • Understand Before You Invest
  • Choose Regulated Investment Products
  • Start Early, Stay Invested
  • Beware of Investment Frauds

Reporting of Short Sell Transactions by Clients:

Clients must report any short sale transaction, by emailing help@dhan.co with the subject “Reporting of Short Sell” on the same day.


Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is just acting as a distributor of Mutual Fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details | MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors | Master Circular for Online Dispute Resolution | Project Jagrook by SEBI